
July 2023 to June 2024
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $580,481,723 | 68,151 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $568,739,037 | 26,609 |
| NIVOLUMAB | $449,309,956 | 62,270 |
| USTEKINUMAB | $438,169,758 | 60,484 |
| MOLNUPIRAVIR | $437,283,193 | 375,268 |
| AFLIBERCEPT | $426,681,828 | 436,414 |
| DUPILUMAB | $368,329,580 | 214,559 |
| APIXABAN | $346,226,428 | 4,158,579 |
| NIRMATRELVIR (&) RITONAVIR | $333,261,814 | 273,750 |
| DENOSUMAB | $297,581,268 | 1,178,893 |
| SEMAGLUTIDE | $289,631,929 | 2,435,812 |
| ADALIMUMAB | $248,619,342 | 358,679 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $121,075,500 | 17,021,070 |
| ATORVASTATIN | $94,564,449 | 11,878,365 |
| PANTOPRAZOLE | $86,104,330 | 10,837,941 |
| ESOMEPRAZOLE | $74,404,672 | 8,271,045 |
| PERINDOPRIL | $48,811,489 | 6,979,964 |
| ESCITALOPRAM | $28,413,121 | 6,431,687 |
| METFORMIN | $48,921,324 | 6,169,020 |
| SERTRALINE | $29,344,102 | 6,041,659 |
| AMOXICILLIN | $20,378,359 | 5,191,251 |
| CEFALEXIN | $26,848,281 | 5,131,002 |
| AMLODIPINE | $36,666,293 | 4,961,882 |
| TELMISARTAN | $29,574,026 | 4,495,060 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $18,111,454,280 |
| Patients | $3,574,578,303 |